Efficacy of a Single Image Guided Injection of CTM for Glenohumeral Arthritis

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 22, 2022

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2025

Conditions
Osteoarthritis ShoulderGlenohumeral OsteoarthritisShoulder Osteoarthritis
Interventions
DEVICE

CTM Injection

All glenohumeral joint injections will be performed by a physician under the guidance of either ultrasound or fluoroscopy to ensure and document intra-articular needle placement. 2cc of CTM Flow will be injected. The glenohumeral joint will be injected with the medication under the discretion of the treating surgeon.

Trial Locations (1)

46260

Indiana Hand to Shoulder Center, Indianapolis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

CTM Biomedical

INDUSTRY

lead

Indiana Hand to Shoulder Center

OTHER

NCT06171542 - Efficacy of a Single Image Guided Injection of CTM for Glenohumeral Arthritis | Biotech Hunter | Biotech Hunter